Commentary
Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario
Joe T.R. Clarke, Dominick Amato and Raisa B. Deber
CMAJ September 04, 2001 165 (5) 595-596;
Joe T.R. Clarke
Dr. Clarke is with the Department of Pediatrics, Hospital for Sick Children and University of Toronto, and the Department of Health Administration, University of Toronto, Toronto, Ont.. Dr. Amato is with the Department of Medicine, University of Toronto, Toronto, Ont. Dr. Deber is with the Department of Health Administration, University of Toronto, Toronto, Ont.
Dominick Amato
Dr. Clarke is with the Department of Pediatrics, Hospital for Sick Children and University of Toronto, and the Department of Health Administration, University of Toronto, Toronto, Ont.. Dr. Amato is with the Department of Medicine, University of Toronto, Toronto, Ont. Dr. Deber is with the Department of Health Administration, University of Toronto, Toronto, Ont.
Raisa B. Deber
Dr. Clarke is with the Department of Pediatrics, Hospital for Sick Children and University of Toronto, and the Department of Health Administration, University of Toronto, Toronto, Ont.. Dr. Amato is with the Department of Medicine, University of Toronto, Toronto, Ont. Dr. Deber is with the Department of Health Administration, University of Toronto, Toronto, Ont.
Data supplements
This item has the following additional materials available:
Related Articles
In this issue
Article tools
Respond to this article
Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario
Joe T.R. Clarke, Dominick Amato, Raisa B. Deber
CMAJ Sep 2001, 165 (5) 595-596;